SCHEDULE 13G/A: Dimensional Fund Advisors Reports 4.6% Stake in USANA

Dimensional Fund Advisors LP has filed an amended Schedule 13G, disclosing a 4.6% beneficial ownership stake in USANA Health Sciences Inc. as of December 31, 2025.

Summary

• Dimensional Fund Advisors LP, an investment adviser, reported beneficial ownership of 848,452 shares of Common Stock in USANA Health Sciences Inc.
• This ownership represents 4.6% of the class of securities.
• Dimensional Fund Advisors LP holds sole voting power over 829,834 shares and sole dispositive power over 848,452 shares.
• The securities are held by various funds for which Dimensional Fund Advisors LP acts as an investment adviser, sub-adviser, and/or manager.
• The filing certifies that the securities were acquired and are held in the ordinary course of business and not for the purpose of changing or influencing control of the issuer.

Sentiment

Score: 5

Explanation: This is a routine beneficial ownership disclosure (Schedule 13G) and does not inherently carry positive or negative sentiment regarding the issuer's performance or prospects. It is a factual report of an institutional holding.

Future Outlook

NA

Management Comments

• Dimensional Fund Advisors LP certifies that, to the best of its knowledge and belief, the securities were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer.

Industry Context

NA

Stakeholder Impact

• Shareholders: The filing indicates a significant institutional investor, Dimensional Fund Advisors LP, holds a 4.6% stake in USANA Health Sciences Inc., which may be viewed as a vote of confidence in the company by a major investment adviser.

Key Dates

Keywords

USANA Health Sciences, Dimensional Fund Advisors, Schedule 13G, Beneficial Ownership, Common Stock, Investment Adviser, SEC Filing